Femasys Inc. (FEMY): Company Short-Term Debts

Public company logo of Femasys Corporation (FEMY)

Femasys Inc. (FEMY) profitability is based on the recognition of non-invasive methods and insurance coverage for FemaSeed. The GURU.Markets website tracks the evolution of short-term debt load, where the 0.00 mark serves as the current indicator. Management aims to rapidly implement minimally invasive systems, while portfolio diversification through the commercial scaling of new diagnostic products reduces the risks of dependency on a single solution.

FEMY (Femasys) Company Short-Term Debts history from 07/04/2022 to 10/30/2026

Analytical breakdowns for Femasys Corporation (FEMY)

- stock price and consensus target price:
Stock Price Femasys|FEMY - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Femasys Inc.|FEMY - Real Price to Acquire Entire Company
- business book valuation details:
Book Value per Share Femasys|FEMY - Book Capitalization|Market Value to Book Value Ratio femasys.com|FEMY - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Femasys Inc.|FEMY - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Femasys Inc.|FEMY - Company Total Debt Obligations|Debt to Book Capitalization Ratio Femasys Inc.|FEMY - Company Long-Term Indebtedness|Company Short-Term Debt Femasys|Quick Liquidity Indicator femasys.com
- net income and valuation multiples indicators:
FEMY - Profit After Payment of Taxes
Fundamental company analysis:FEMY - Femasys
Flagship merchandise of Femasys Corporation

Investors are assessing the margin of safety for Femasys Inc. (FEMY) through the volume of liabilities maturing within one year, which determines the liquidity risk during refinancing. The development of the minimally invasive women's healthcare ecosystem requires precise monitoring of short-term borrowed resources on GURU.Markets, where an increasing load signals capital strain, shifting the asset into a higher-risk category.

Direct competitors

Intuitive - Company Short-Term Debts|Short-Term Debt Volume Danaher Corporation DHR|BDX: Company Short-Term Debts|Company Current Liabilities STERIS Group|WST (West Pharmaceutical Services) - Company Short-Term Debts|Company Short-Term Debts baxter.com|Company Short-Term Debt Masimo (MASI)|Company Short-Term Debt STVN (Stevanato Group SpA)|Teleflex Inc - Company Current Liabilities|Company Short-Term Loans and Borrowings MMSI|Envista Holdings - Company Short-Term Debts|Short-Term Debt Volume icumed.com ICUI|Dentsply Sirona (XRAY) - Company Short-Term Debt|Company Short-Term Indebtedness LMAT|Company Short-Term Debt AtriCure Corp|STAAR Surgical Co (STAA) - Short-Term Debt Volume|Company Current Liabilities NAGE (ChromaDex)|Amount of Current Liabilities ZIMV|Company Short-Term Debt AngioDynamics ANGO|Company Short-Term Loans and Borrowings CERS|TKNO: Company Current Liabilities|MGRM - Company Short-Term Debts|sharpstechnology.com (STSS) - Company Short-Term Debt|Company Current Liabilities InfuSystem Holdings, Inc.|UTMD (Utah Medical Products, Inc.) - Company Short-Term Debts|Short-Term Debt KORU Medical Systems Inc. KRMD|Company Short-Term Debt Nyxoah, S.A. (NYXH)|Microbot Medical, Inc - Company Short-Term Indebtedness|Pro-Dex, Inc. - Company Current Liabilities|Amount of Current Liabilities ZTEK (zentek.com)|ELUT - Company Short-Term Debt|Short-Term Debt Volume Milestone Scientific Inc MLSS|NXGL: Company Short-Term Debts|Current Liabilities RVP (Retractable Technologies, Inc.)|HBIO (Harvard Bioscience) - Company Short-Term Debts|Short-Term Debt Meihua Medical MHUA|Company Short-Term Debt Predictive Oncology (POAI)|Company Current Liabilities callanjmb.com CJMB|Company Short-Term Debts ATRI (Atrion Corp)|Company Short-Term Debts NeuroMetrix Corporation NURO